Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Revisão |
| שפה: | אנגלית |
| יצא לאור: |
2020
|
| גישה מקוונת: | https://doi.org/10.1080/14737159.2020.1768849 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
היה/י הראשונ/ה לכתוב הערה!